David H. Crean

David H. Crean is a seasoned professional in the healthcare and life sciences sectors, currently serving as General Partner at 1004 Venture Partners and Managing Partner at Cardiff Advisory LLC, a strategic M&A advisory firm. Additionally, David holds key roles as Chief Business Officer at MediciNova, Inc., Venture Partner at VU Venture Partners, and Forum Leader for Life Sciences and Healthcare at REF. David co-founded CEOthreesixty, facilitating peer-to-peer collaboration among Life Sciences CEOs. David also contributes to the boards of Connect and Cenna Biosciences, a company focused on innovative Alzheimer's treatments. Educational credentials include a Ph.D. in Biophysics, an MBA in Finance, and multiple degrees in natural sciences and pre-med studies from prestigious institutions such as the University at Buffalo and Canisius University.